Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area mapk mapk rasgap ras p21'

Search results for: 'research area mapk mapk rasgap ras p21'

Items 11-20 of 25

Page
per page
  1. BIX 02189
    A5801 BIX 02189
    Target: MEK|ERK
    Summary: Selective MEK5 inhibitor
      ≥22.05 mg/mL
  2. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  3. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  4. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  5. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  6. kobe2602
    B3587 kobe2602
    Summary: Ras inhibitor
      insoluble in H2O; ≥17 mg/mL
  7. FRAX597
    B1162 FRAX597
     1 Citation
    Target: PAK
    Summary: PAK inhibitor,potent and ATP-competitive
      ≥27.9 mg/mL
  8. Pexmetinib (ARRY-614)
    B6012 Pexmetinib (ARRY-614)
    Target: p38|Tie-2
    Summary: dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase
      insoluble in H2O; ≥107.6 mg/mL
  9. Erastin
    B1524 Erastin
    Target: Ras
    Summary: cell-permeable ferroptosis activator and antitumor agent
      insoluble in H2O; insoluble in EtOH; ≥10.92 mg/mL
  10. SB 431542
    A8249 SB 431542
     2 Citation
    Summary: ALK inhibitor

Items 11-20 of 25

Page
per page